IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Nov 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-11-05

Reporting Person: MAZELSKY JONATHAN JAY (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-05	Common Stock	S	355	$463.4548	Disposed	43996	Direct
2020-11-05	Common Stock	S	1307	$465.0234	Disposed	42689	Direct
2020-11-05	Common Stock	S	107	$465.8077	Disposed	42582	Direct
2020-11-05	Common Stock	S	310	$467.3319	Disposed	42272	Direct
2020-11-05	Common Stock	S	400	$468.9235	Disposed	41872	Direct
2020-11-05	Common Stock	S	714	$470.3444	Disposed	41158	Direct
2020-11-05	Common Stock	S	264	$471.3391	Disposed	40894	Direct
2020-11-05	Common Stock	S	247	$473.99	Disposed	40647	Direct
2020-11-05	Common Stock	S	200	$475.1780	Disposed	40447	Direct
2020-11-05	Common Stock	S	300	$476.73	Disposed	40147	Direct
2020-11-05	Common Stock	S	209	$468.465	Disposed	39938	Direct
2020-11-05	Common Stock	S	246	$469.8567	Disposed	39692	Direct
2020-11-05	Common Stock	S	100	$470.79	Disposed	39592	Direct
2020-11-05	Common Stock	S	147	$473.99	Disposed	39445	Direct
2020-11-05	Common Stock	S	300	$476.73	Disposed	39145	Direct
2020-11-05	Common Stock	G	600	—	Disposed	38545	Direct
2020-11-06	Common Stock	M	1612	$62	Acquired	40157	Direct
2020-11-06	Common Stock	M	1256	$79.54	Acquired	41413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-06	Incentive Stock Option (right-to-buy)	$62	M	1612	Disposed	2024-02-13	Common Stock (1612)	Direct
2020-11-06	Incentive Stock Option (right-to-buy)	$79.54	M	1256	Disposed	2025-02-13	Common Stock (1256)	Direct

Footnotes

F1: Includes 18 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020.

F2: Represents the weighted average price of the shares sold ranging from a low of $463.195 to a high of $463.59 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $464.628 to a high of $465.55 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $465.79 to a high of $466.06 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $467.30 to a high of $468.29 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Represents the weighted average price of the shares sold ranging from a low of $468.796 to a high of $468.966 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F7: Represents the weighted average price of the shares sold ranging from a low of $469.96 to a high of $470.62 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F8: Represents the weighted average price of the shares sold ranging from a low of $471.17 to a high of $472.10 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F9: Represents the weighted average price of the shares sold ranging from a low of $475.04 to a high of $475.33 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F10: Represents the weighted average price of the shares sold ranging from a low of $468.04 to a high of $468.95 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F11: Represents the weighted average price of the shares sold ranging from a low of $469.31 to a high of $470.25 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F12: Grant of option to buy 806 shares of IDEXX Laboratories, Inc. common stock that vested on the fifth anniversary of the date of grant without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F13: Grant of option to buy 628 shares of IDEXX Laboratories, Inc. common stock that vested on the fifth anniversary of the date of grant without giving effect to Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F14: Not applicable.